Compare iShares MSCI Japan ETF (EWJ) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Japan ETF vs Tenet Healthcare Corporation — how do they compare? iShares MSCI Japan ETF trades at $97.5 (market cap $24.21B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: iShares MSCI Japan ETF is the larger of the two by market cap, and Tenet Healthcare Corporation is more actively traded (455,764 versus 2,672,665). Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Japan ETF for 56 Days and Tenet Healthcare Corporation for 15 Days on average.
| EWJ | THC | |
|---|---|---|
Market Cap | $24.21B | $20.92B |
Volume | 2,672,665 | 455,764 |
Sector | Broad Market / Factor | Health |
52-Week High | $99.32 | $280.77 |
52-Week Low | $78.36 | $161.37 |
Typical Hold Time | 56 Days | 15 Days |
Enterprise Value | — | $32.00B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWJ, the iShares MSCI Japan ETF, trades at $98.32, down 1.01% amid broader Asian market volatility. Technical indicators show a bullish moving average signal but neutral oscillators, with key support at $97 and resistance at $99. Recent news highlights Japan's monetary policy uncertainty as the BOJ navigates rate hikes and yen intervention efforts, creating both opportunities and risks for Japan-focused investors.
The outlook for EWJ remains cautiously optimistic given Japan's economic stimulus efforts and AI sector growth potential, though rising bond yields and currency volatility present significant headwinds. Investors should monitor BOJ policy decisions and yen stability as key catalysts for near-term performance.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About iShares MSCI Japan ETF
EWJ tracks the MSCI Japan Index, providing broad exposure to over 180 large and mid-cap companies in Japan. It is the most established and liquid vehicle for accessing the Japanese equity market, featuring a diversified portfolio across industrials, consumer discretionary, and financial sectors.
Read more on EWJ →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
